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Can tryptophan supplement intake at
breakfast enhance melatonin secretion at
night?
Shunsuke Nagashima1,2, Makoto Yamashita1, Chiaki Tojo1, Masayuki Kondo3, Takeshi Morita4
and Tomoko Wakamura1*
Abstract
Background: Tryptophan (TRP) is an essential amino acid, and it has been suggested that TRP intake at breakfast
combined with daytime bright light exposure can increase nocturnal melatonin secretion. However, the mechanisms
involved are not yet clear. The aim of this study was to examine the effect of TRP supplement intake at breakfast on
nocturnal melatonin secretion under different daytime light intensities in humans.
Method: Twelve subjects (aged 21.3 ± 3.0 years, mean ± standard deviation) participated in a random order in
experimental sessions lasting 3 days under four conditions in a laboratory setting. The four conditions were TRP*Bright,
Placebo*Bright, TRP*Dim, and Placebo*Dim. A TRP capsule (1000 mg) or a placebo starch capsule (1000 mg) were
taken at breakfast. In addition, during the daytime (07:00–18:00), the subjects were asked to stay under different light
intensities: >5000 lx (bright) or <50 lx (dim). Saliva samples were collected for measuring the concentration of
melatonin. The time courses of melatonin concentration and dim light melatonin onset (DLMO) were compared
among the four conditions using repeated measurements analysis of variance (ANOVA).
Result: Nocturnal melatonin concentrations in the bright light condition tended to be higher than in the dim light
condition (main effect of light: p = .099). Moreover, in the bright light condition, the change in DLMO between baseline
and after the intervention was significantly higher than that in the dim light condition (main effect of light: p <.001).
However, the ANOVA results indicated no significant effect of TRP intake on melatonin secretion.
Conclusion: Our findings indicated that intake of 1000 mg of TRP at breakfast on 1 day did not change nocturnal
melatonin secretion, even though TRP is the precursor of melatonin. In contrast, daytime bright light exposure
increased nocturnal melatonin secretion and advanced the phase of melatonin onset. Therefore, TRP supplementation,
unlike exposure to daytime bright light, does not acutely affect biological rhythm and sleep in humans.
Trial registration: UMIN Clinical Trial Registry: UMIN000024121
Keywords: Tryptophan, Bright light exposure, Breakfast, Melatonin, Dim light melatonin onset
Background
Tryptophan (TRP) is an essential amino acid in humans.
Humans cannot produce TRP sufficiently by themselves,
so this amino acid must be absorbed in the small intes-
tine from protein-rich foods (for example, milk, eggs,
meat, and beans). TRP is metabolized into melatonin via
the serotonin pathway. Melatonin, a hormone produced
by the pineal gland at night, regulates circadian rhythms
and sleep–wake cycles in humans. Therefore, several pre-
vious studies have suggested that TRP intake at night
could improve nocturnal sleep quality in humans [1].
However, it is not clear when TRP is metabolized to form
the melatonin that is secreted by the pineal gland at night.
Wada et al. [2] reported the effect of a TRP-rich break-
fast in a field study. Their study indicated that salivary
melatonin secretion at 23:00 was increased by consump-
tion of a TRP-rich breakfast with exposure to light of
low color temperature during the night, compared with
no intervention. Furthermore, a laboratory-based study
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by Fukushige et al. [3] reported that melatonin secretion
at night was significantly increased by consumption of a
TRP-rich breakfast with daytime bright light exposure
for 3 days, although the secretion was not significantly
changed by consumption of a TRP-poor breakfast. Both
field and laboratory-based studies indicated that mela-
tonin secretion at night might be increased by TRP in-
take in the morning if there is exposure to bright light
during the daytime. However, these studies had some
limitations, for example, a lack of control of daily nutri-
tion and the duration of daily light exposure (which was
dependent upon the amount of sunlight).
For melatonin synthesis in the brain, TRP must be
transported into the brain through the blood–brain bar-
rier (BBB). When TRP passes through the BBB, it com-
petes with large neutral amino acids (LNAAs: isoleucine,
leucine, phenylalanine, tyrosine, and valine). Therefore, a
higher plasma TRP/LNAA ratio (mol/mol) is favorable
for TRP transportation through the BBB. The plasma
TRP/LNAA ratio has been used as an indicator of sero-
tonin synthesis in the brain in both animal and human
studies [4–7]. This ratio depends on the contents of a
meal; it is increased by intake of TRP-rich protein [7]
and carbohydrates [8–10] and decreased by intake of
LNAA-rich protein. In Fukushige et al.’s study [3], the
TRP/LNAA ratios of both TRP-rich and TRP-poor foods
were very similar; therefore, it was difficult to conclude
that the increase in melatonin secretion at night was due
to the TRP-rich breakfast alone. It is necessary to con-
trol the intakes of other nutrients in order to elucidate
the effect of TRP intake in the morning on nocturnal
melatonin secretion. For the same reason, although TRP
intake did not significantly advance subjects’ circadian
phases in the study by Fukushige et al. [3], their results
were not clear. Nakade et al. [11] reported a positive
correlation between the estimated amount of TRP intake
at breakfast and Morningness-Eveningness Questionnaire
(MEQ) score in children, suggesting that children con-
suming a higher amount of TRP at breakfast may have an
earlier circadian acrophase. Thus, further examination of
whether melatonin onset can be advanced by TRP intake
at breakfast is needed.
The aim of this study was to investigate if TRP supple-
ment intake at breakfast could enhance nocturnal mela-
tonin secretion, after adjusting for light exposure and
intakes of TRP, LNAA, and other nutrients. In this
study, we compared the profiles of nocturnal melatonin
secretion between individuals taking a TRP or placebo
supplement at breakfast.
Methods
Subjects and experimental conditions
The subjects were male university students recruited
voluntarily using a website and posters. None of the
subjects had a history of night shift working, tobacco
smoking, taking medications, food allergy, or traveling
across time zones for a month prior to the experiment.
The participants who had mental or physical disorders
(determined by the Cornell Medical Index, CMI [12, 13]),
sleep disorders (determined by the Pittsburgh Sleep
Quality Index, PSQI [14, 15]), or who were extreme morn-
ing or evening types (determined by the MEQ [16, 17])
were excluded from the study. Initially, 14 subjects partici-
pated in the experiment; however, only 12 of these (aged
21.3 ± 3.0 years, mean ± standard deviation, range 18–
26 years; body mass index 21.8 ± 2.6 kg/m2, range 18.5–
26.1 kg/m2) were able to complete the experimental
protocol.
All subjects participated in four conditions, under-
taken in a random order, with more than a week between
each condition. The four conditions were as follows.
TRP*Bright condition, TRP supplement (1000 mg) at
breakfast (at 08:00) with bright light exposure (>5000 lx at
eye level) during the daytime (between 07:00 and 18:00);
Placebo*Bright condition, placebo supplement (starch,
1000 mg) at breakfast with daytime bright light exposure;
TRP*Dim condition, TRP supplement at breakfast with
daytime dim light exposure (<50 lx); and Placebo*Dim
condition, placebo supplement at breakfast with daytime
dim light exposure.
The amount of TRP intake at breakfast was based on
previous studies. Schneider-Helmert and Spinweber [18]
concluded that L-TRP should be administered at a dose
of more than 1000 mg to obtain reliable effects on sleep,
and Hiratsuka et al. [19] reported that the addition of
1000 to 5000 mg of TRP per day (332 to 1660 mg per
meal) had no adverse effects in healthy Japanese women.
Accordingly, the participants ingested 1000 mg of TRP
at breakfast in the two TRP-containing conditions. With
respect to the light condition, Fukushige et al. [3] re-
ported that the pattern of TRP metabolism differed de-
pending on the intensity of daytime light. In the present
study, we examined the patterns of TRP metabolism
under both bright (>5000 lx) and dim (<50 lx) light
conditions.
Experimental protocol
The experimental protocol is illustrated in Fig. 1. The
subjects were asked to keep to a regular sleep–wake
cycle (going to bed at 24:00 and waking up at 07:00) for
3 days prior to the experiment. Throughout this period,
adherence to these requirements was confirmed by ob-
jective measurements of activity with an Actiwatch
(Mini-Mitter Co. Inc., OR, USA).
This experiment was carried out in a living facility
consisting of several rooms, one of which each subject
stayed in throughout the experiment. Each room was
equipped with a bed, table, toilet, and bathroom. The
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room temperature was controlled within a narrow range
(25 ± 2 °C). The subjects were asked to wear a short-
sleeved T-shirt and long pants during the experiment. In
the experimental rooms, all light sources and windows
were covered by black cellophane and black panels, re-
spectively, to create a dim condition. In addition, all cur-
tains were closed in the dim light condition. In this
condition, the intensity of the light was <50 lx at eye
level when the subject was standing.
On the first day of the experiment, the subjects en-
tered the experimental room with a dim light environ-
ment at 18:00. They then took a shower and ate supper
in the experimental room. Salivary samples were col-
lected every hour between 21:00 and 24:00 under dim
light. After collection of the last saliva sample, they went
to bed in the dark (0 lx) at 24:00.
On the second day, the subjects woke at 07:00 and
those in the TRP*Dim or Placebo*Dim condition
remained in dim light between 07:00 and 18:00. In the
TRP*Bright or Placebo*Bright conditions, the subjects
stayed in natural sunlight by opening the curtains and
taking off the window and light coverings. Moreover, a
lighting device (Bright Light Me, Solartone Ltd., Tokyo,
Japan) was placed in front of them. A light intensity of
>5000 lx was measured at eye level when subjects were
sitting in front of the lighting device. The subjects were
instructed to spend their free time in front of this device.
From 18:00 onwards, all subjects lived in the dim light
condition. Breakfast, lunch, and supper were served at
07:30, 12:00, and 19:00, respectively. The subjects were
required to eat each meal within a 30-min period. The
estimated nutritional values of each meal are shown in
Table 1. The nutritional values were based on the
Standard Tables of Food Composition in Japan [20]. The
capsule (L-tryptophan, 1000 mg: Source Naturals, Inc.,
CA, USA; or placebo, starch 1000 mg: Maeda Co., Ltd,
Ehime, Japan) was taken at 08:00, immediately after
breakfast. On the second day, saliva samples were col-
lected every hour between 18:00 and 24:00. After the last
saliva sample, the subjects emptied their bladder and
went to bed. During sleep time, the subjects were woken
to collect saliva samples at 01:00, 03:00, and 05:00 in the
dark (0 lx). On the morning of the third day, after col-
lecting a urine sample at 07:00, the subjects were free to
leave the experiment. If a subject wanted to pass urine
from 24:00 to 07:00, the urine samples were collected
into a bottle until 07:00 and acidified with the addition
of hydrochloric acid. They were allowed to drink water
freely, to read books, and to listen to music throughout
the experiment. However, excessive physical exercise,
taking a nap, watching TV, and using a mobile phone or
computer were not permitted.
Measurements
In this study, salivary melatonin concentrations and
creatinine-adjusted urinary melatonin concentrations
were measured as indicators of the nocturnal secretion
of melatonin. Dim light melatonin onset (DLMO) was
calculated from the profile of salivary melatonin concen-
trations to assess the phase of nocturnal melatonin se-
cretion. DLMO is often used to assess the phase of
biological rhythms [21]; in this study, the time of the
DLMO was determined by linear interpolation between
the time points before and after the melatonin concen-
tration increased and stayed above the 3.3 pg/ml thresh-
old [22, 23].
The saliva samples from all subjects were placed in
collection tubes using a pure cotton swab (Sarstedt
Fig. 1 The experimental protocol. Horizontal bars indicate
experimental light conditions; gray, black, and white represent dim
(<50 lx), dark (0 lx), and bright (>5000 lx) lights, respectively. Arrows
indicate the times of data collection; gray and white arrows indicate
saliva and urine collection times, respectively. Gray triangles show
the times of meals
Table 1 Energy and nutrient intakes at breakfast, lunch, and
supper
Energy and nutrients Breakfast (TRP/placebo) Lunch Supper
Energy (kJ) 1582 3406 4004
Tryptophan (mg) 1051.9/51.9 307 300
Protein (g) 4.3 26.1 27.1
Lipid (g) 7.9 15.6 29.3
Carbohydrate (g) 72.3 139.5 143.0
Isoleucine (mg) 154.0 370.4 1064.3
Leucine (mg) 296.5 684.6 1887.1
Phenylalanine (mg) 185.7 453.1 1083.7
Tyrosine (mg) 137.6 319.8 814.7
Valine (mg) 207.9 503.1 1249.2
LNAA (mg) 981.7 2330.9 6099.0
TRP/LNAA ratio (mol/mol) 0.727/0.036 0.089 0.033
Energy and nutrient contents of each meal were calculated from the Standard
Tables of Food Composition in Japan [20]
LNAA large neutral amino acids (isoleucine, leucine, phenylalanine, tyrosine,
valine), TRP tryptophan
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AG & Co., Nümbrecht, Germany). All salivary samples
were immediately centrifuged at 1500g for 5 min and fro-
zen at −20 °C until analysis. The urine samples were also
stored at −20 °C. The saliva samples were analyzed for
melatonin using RIA kits (RK-DSM2 200 tests, Bühlmann
Laboratories AG, Schönenbuch, Switzerland). The mean
inter-assay and intra-assay coefficients of variation (CV)
were 7.9 and 9.8%, respectively. The limit of detection
(LoD) was 0.2 pg/ml, and the limit of quantification (LoQ)
was 0.9 pg/ml.
The urine samples were analyzed for melatonin with
RIA kits (RK-MEL2 200 tests, Bühlmann Laboratories
AG, Schönenbuch, Switzerland). The mean intra- and
inter-assay CVs were 7.9 and 11.7%, respectively. The
LoD was 0.3 pg/ml, and the LoQ was 0.9 pg/ml. Creatin-
ine was analyzed using creatinine kits (Determiner L
CRE, Kyowa Medex Co. Ltd., Tokyo, Japan). The mean
intra- and inter-assay CVs were <5 and <3%, respect-
ively. The LoD was 0.04 mg/dl, and the LoQ was
0.1 mg/dl. All samples were measured by SRL Co. Ltd.
(Tokyo, Japan).
Statistical analysis
Two participants did not complete the experimental
protocol, so data from 12 participants were analyzed. In
this study, we compared the time courses of salivary
melatonin concentration (from the second to the third
day), DLMO, and creatinine-adjusted urine melatonin
concentration among the four conditions.
The time courses of salivary melatonin concentration
were analyzed by three-way repeated measures ANOVA
analysis of variance (ANOVA); TRP (TRP vs. placebo in-
take), light (bright light vs. dim light), and time of day
were the within-subject factors. Creatinine-adjusted
urine melatonin concentrations measured in the morn-
ing of the third day were compared among conditions
by using two-way repeated measures ANOVA. DLMOs
were compared between the first and second day in each
condition using paired t tests. The change in DLMO
was compared among the four conditions using two-way
repeated measures ANOVA; TRP/placebo and light in-
tensity were the within-subject factors. For all ANOVAs,
if the sphericity assumption was not met, the degrees of
freedom were modified using the Greenhouse–Geisser
method. When any main effects and interactions were
significant, the Bonferroni method was used for multiple
comparisons.
Data are provided as the mean ± standard error of the
mean (SEM), and effect sizes are described with p values.
Cohen’s dz was used as the effect size in paired t tests
and multiple comparison of ANOVA, and partial η2 was
also used in ANOVA. The sample size was n = 12, which
was calculated by the effect size as follows: dz = 1.2 from
the result of DLMO in a previous study [24], alpha
error = .0083 (alpha error was modified from .05 for
multiple comparisons between the four conditions
using the Bonferroni method), and beta error = .80 on
the two-tailed test. Statistical analyses were performed
using SPSS ver. 21 (IBM, Tokyo, Japan), and a p value
of <.05 was considered to be significant.
Ethical considerations
The subjects received an explanation of the research
purpose and the experimental protocol from the chief
investigator, and informed consent was obtained from
each subject before participating in this experiment. This
experimental protocol was conducted in accordance
with the Declaration of Helsinki and approved by the
Ethics Committee at Fukuoka Women’s University.
Results
The time course of nocturnal melatonin concentration
The time courses of nocturnal saliva melatonin concen-
tration are illustrated in Fig. 2, and the results from the
three-way repeated measures ANOVA are shown in
Table 2. There was no significant main effect of TRP
intake (p = .139, F(1, 11) = 2.55, partial η
2 = .188), and no
interactions were significant. Only the main effect of
time was significant (p <.001, F(1.81, 19.93) = 25.62, par-
tial η2 = .700), and there was a trend towards a signifi-
cant main effect of light (p = .099, F(1, 11) = 3.25, partial
η2 = .228).
Dim light melatonin onset
The DLMOs are shown in Table 3. Since the DLMOs of
four subjects could not be assessed during the sampling
period (their melatonin levels did not rise above the ab-
solute threshold (3.3 pg/ml)), their data were excluded
Fig. 2 The time courses of salivary melatonin secretion in the four
conditions. Bright light and dim light conditions are indicated by the
black line and gray line, respectively. TRP supplementation and
placebo supplementation conditions are illustrated by solid and
dotted lines, respectively. The error bars indicate the standard errors
of the means
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from the analysis. The DLMOs on the second day
were significantly earlier than those on the first day
in the TRP*Bright and Placebo*Bright conditions (p = .001,
dz = 1.81 and p = .002, dz = 1.73, respectively). However, in
the TRP*Dim and Placebo*Dim conditions, there was no
significant difference between the DLMOs on the first and
second days (TRP*Dim condition: p = .050, dz = 0.84; and
Placebo*Dim: p = .118, dz = 0.63, respectively). Regarding
changes in DLMO (Tables 3 and 4), two-way repeated
measures ANOVA showed a significant main effect of
light (p <.001, F(1, 7) = 42.03, partial η
2 = .857). Post hoc
tests indicated the change in DLMO in the bright light
condition was significantly greater than that in the dim
light condition. The main effect of TRP and the inter-
action between TRP and light were not significant.
Creatinine-adjusted urine melatonin
The creatinine-adjusted melatonin concentrations in
urine on the morning of the third day are illustrated in
Fig. 3. Two-way repeated measures ANOVA indicated
that the values in the bright light conditions were signifi-
cantly higher than those in the dim light conditions
(p = .038, F(1, 11) = 0.29, partial η
2 = .026). However, TRP
supplementation had no significant effect (p = .599,
F(1, 11) = 5.53, partial η
2 = .335), and the interaction
between TRP and light was also not significant (p = .730,
F(1, 11) = 0.13, partial η
2 = .011).
Discussion
Our results showed that nocturnal melatonin secretion
was increased by exposure to bright light in the daytime
after only 1 day. This result is supported by several pre-
vious studies. Hashimoto et al. [25] reported that expos-
ure to bright light (~5000 lx) in the daytime for three
consecutive days significantly advanced the onset of noc-
turnal melatonin secretion in young people. In addition,
Takasu et al. [26] reported that the amplitude of noctur-
nal melatonin secretion was higher when subjects were
exposed to daytime bright light for 7 days than when
they were exposed to dim light for the same duration.
Furthermore, other studies have indicated that daytime
bright light exposure could prevent melatonin suppres-
sion induced by nighttime light [27, 28]. Therefore, in
the dim light conditions of our experiment, it is possible
that nocturnal melatonin suppression may have been
due to exposure to a light intensity of less than 50 lx.
The effects of bright light exposure were very strong
and their effect sizes were very large (dz = 1.97 after TRP
supplementation and dz = 2.21 after placebo supplemen-
tation; see Additional file 1A). The advance in the phase
of nocturnal melatonin secretion after daytime exposure
to bright light was consistent with several previous stud-
ies [25, 29, 30]. A previous experimental study, which
used an isolation unit without temporal information, in-
dicated that the sleep–wake cycle and the rhythm of the
core body temperature were advanced by a single expos-
ure to bright light (of 3- or 6-h duration) given early in
the day (in the morning) [31]. Our findings also suggest
that 1 day of diurnal bright light exposure might be ef-
fective in advancing delayed biological rhythms, such as
those found in delayed sleep phase syndrome and some
circadian and sleep disorders, in real life.
One aim of our study was to investigate whether TRP
supplementation at breakfast increased the secretion of
melatonin at night and/or advanced the phase of mela-
tonin secretion. However, a TRP supplementation of
Table 2 Analysis of variance results for the time courses of
salivary melatonin secretion
p value F value(df) Partial η
2 value
Main effect of TRP .139 2.55(1, 11) .188
Main effect of light .099 3.25(1, 11) .228

















aThe degrees of freedom were modified using the Greenhouse–Geisser
method because the assumption of sphericity was not met
TRP tryptophan
Table 3 DLMOs in the four conditions (n = 8)
Day 1 DLMO (h:min) Day 2 DLMO (h:min) p value t value dz value Δ DLMOa (min)
TRP*Bright 22:51 ± 0:11 21:53 ± 0:17 .001 5.12 1.81 +58.5 ± 11.4
Placebo*Bright 22:26 ± 0:12 21:40 ± 0:15 .002 4.89 1.73 +46.6 ± 9.5
TRP*Dim 22:01 ± 0:09 22:24 ± 0:14 .050 2.37 0.84 −22.7 ± 9.6
Placebo*Dim 22:21 ± 0:12 22:35 ± 0:17 .118 1.78 0.63 −13.8 ± 7.8
A DLMO was not detected for four subjects during the sampling period; therefore, their data were excluded from this analysis. All data are shown as the mean ±
standard error of the mean. Times for day 1 DLMO and day 2 DLMO are presented as clock time (h:min). Δ DLMO = change in DLMO (min)
DLMO dim light melatonin onset
aA positive value for Δ means that the DLMO on the second day had advanced from its value on the first day
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1000 mg at breakfast for 1 day did not exert such effects.
The results of the present study were inconsistent with
those of Fukushige et al. [3] and with other studies sug-
gesting that TRP intake might improve human sleep by
increasing nocturnal melatonin secretion [2, 11, 32].
This disagreement may have arisen from the following
four reasons.
First, the period of TRP intake in our study was differ-
ent from that in the study by Fukushige et al. [3]. Our
participants took 1000 mg of TRP at breakfast for only
1 day, whereas in the study by Fukushige et al., a TRP-
rich breakfast (including 476 mg of TRP) was eaten for
three consecutive days. This suggests that TRP ingested
in food might need a period of more than 1 day to be
converted into melatonin. This suggestion is supported
by a study of the circadian rhythms of serum TRP and
blood serotonin in humans. Rao et al. [33] reported that
the acrophase of the circadian rhythm of the blood sero-
tonin levels was earlier by 5.1–6.5 h than that of the
serum TRP levels in both schizophrenic and healthy
humans. TRP is a precursor of serotonin; therefore, it is
reasonable to suppose that TRP would be metabolized
into serotonin for more than 17.5 h. Accordingly, if the
duration of TRP supplementation was longer than in
our study, its effect might have been greater than in the
placebo control condition.
Second, intake of other nutrients affects TRP metabol-
ism. TRP needs several enzymes to be converted into
melatonin [34]. Aromatic L-amino acid decarboxylase
and arylalkylamine N-acetyltransferase are two of the en-
zymes involved in serotonin and melatonin synthesis,
and these enzymes are influenced by the intake of other
nutrients, including vitamin B6 and n-3 fatty acids. That
is, not only TRP intake but also vitamin B6 and n-3 fatty
acid intake might need to be increased in order to con-
vert TRP into melatonin in the brain, even if the TRP
consumed at breakfast has passed through the BBB.
Therefore, it is possible that the combination of TRP
supplementation with the intake of other nutrients in
the morning would more effectively increase the secre-
tion of melatonin at night.
Third, Yao et al. [35] mentioned in their review that
over 95% of ingested TRP is catabolized in the liver via
the kynurenine pathway and that only 1–2% of dietary
TRP is converted into serotonin in healthy adult
humans. Moreover, TRP is converted into serotonin
mainly in the small intestine. This means that very little
of the serotonin in the brain has been converted from
TRP. Therefore, TRP supplementation of 1000 mg might
do little to increase nocturnal melatonin secretion. In
addition, Schneider-Helmert and Spinweber [18] reviewed
studies on the hypnotic efficacy of L-TRP and concluded
that it should be administered at a dose of between 1000
and 5000 mg in order to obtain reliable effects on sleep
(L-TRP was administered 20 min before bedtime), and se-
vere, chronic insomniacs appeared to respond to doses of
L-TRP as low as 1000 mg only after repeated administra-
tion. Similarly, Adam and Oswald [36] reported that there
was no effect of TRP on the latency to sleep onset. There-
fore, TRP supplementation of 1000 mg in the present
study may have been too low to increase melatonin secre-
tion. Further studies investigating the effect of higher
amounts of TRP supplementation in the morning are
needed. However, considering the mechanism of TRP me-
tabolism, taking TRP in order to increase melatonin secre-
tion might not be justified.
Fourth, there were some biases in the present study.
As our subjects were healthy male adults, there was a
“healthy adult” bias. Previous studies have indicated that
TRP intake was significantly effective for patients with
insomnia [18, 37]; however, in healthy adults, melatonin
secretion at night might be sufficient, so that the level of
nocturnal melatonin secretion reaches a peak and would
not be raised further by TRP supplementation. More-
over, age may also be associated with TRP metabolism.
Harada et al. [32] reported that the amount of TRP in-
take at breakfast was significantly correlated with the
inherited circadian type (morning or evening type) in in-
fants and lower grade elementary school students but
that this correlation disappeared in higher grade elemen-
tary school students and junior high school students.
Their findings suggested that any effects of TRP
Table 4 The repeated measures analysis of variance results for
change in dim light melatonin onset
p value F value(df) Partial η
2 value
Main effect of TRP .880 0.03 (1, 7) .004
Main effect of light <.001 42.03 (1, 7) .857
Interaction between TRP and light .115 3.23 (1, 7) .316
TRP tryptophan
Fig. 3 Creatinine-adjusted urinary melatonin in the four conditions
(n = 12). The error bars indicate the standard errors of the means
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supplementation in the morning upon nocturnal mela-
tonin secretion might disappear as individuals grow
older. That is, TRP intake in the morning might affect
nocturnal melatonin secretion only in children.
Our study had some methodological limitations.
Creatinine-adjusted urinary melatonin may not have
been a suitable outcome measure. Urinary melatonin
may still have been secreted at 07:00 because the salivary
melatonin concentration appeared to peak at 05:00.
Therefore, we could not evaluate the total amount of
nocturnal melatonin secretion. Moreover, we collected
saliva samples using a cotton swab. A previous study in-
dicated that cotton swabs might decrease melatonin
levels [38]. For this reason, we could not determine the
DLMO of four subjects, who had melatonin levels lower
than 3.3 pg/ml. Further research is needed to investigate
other ways of measuring melatonin secretion (e.g., serum
melatonin concentration).
Conclusions
Our study examined whether TRP ingested at breakfast
was metabolized in vivo into melatonin at night, adjust-
ing for the biases in Fukushige et al.’s study [3].
However, it was found that 1 day of 1000 mg supple-
mentation with TRP had no significant effect on noctur-
nal melatonin secretion, even though TRP is the
precursor of both serotonin and melatonin. However,
daytime exposure to bright light increased nocturnal
melatonin secretion and advanced the time of DLMO.
These results suggest that a single TRP supplement
would not acutely promote sleep or alter the timing of
biological rhythms in humans, unlike the effects of ex-
posure to bright light in the daytime. In recent years, we
have encountered more and more commercial articles
insisting that TRP intake could improve sleep by in-
creasing nocturnal melatonin secretion. However, these
articles lack scientific evidence and should not be ac-
cepted without question. These articles fail to pay atten-
tion to the mechanisms by which TRP is metabolized. In
order to investigate the possibility that TRP supplemen-
tation improves sleep quality or affects the timing of cir-
cadian rhythms, further studies are needed to examine
the correlation between TRP metabolism and nocturnal
melatonin secretion.
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(DOCX 16 kb)
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